Seattle Genetics' cancer drug put on clinical hold after four deaths

Seattle Genetics' cancer drug put on clinical hold after four deaths


Seattle Genetics Inc said four people had died in trials testing its experimental cancer drug, prompting the U.S. Food and Drug Administration to impose a clinical hold on several early-stage studies. Six patients with acute myeloid leukemia , a type of blood cancer, have been identified with liver toxicity and four have died, the company said on Tuesday.



from Biotech News